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Abstract The aim of the study was to verify if there is
any association between exposure to Cu, Zn, Cd, Pb, As
and the formation of malondialdehyde (MDA), 8-
hydroxydeoxyguanosine (8-OHdG), advanced oxidation
protein products (AOPP), and whether in this process
cigarette smoking plays a role. The investigations were
performed in the 352 smelters occupationally exposed to
heavy metals and 73 persons of control group. Metals
concentration was determined by atomic absorption
spectrometry. MDA and AOPP concentrations were de-
termined by spectrophotometric methods. The concentra-
tion of 8-OHdG was determined by ELISA method. It
was demonstrated an increased Cu concentration in
smoking smelters compared to non-smoking control
group. It was noted no differences in Zn and Mg
concentrations between the examined groups. Pb con-
centration was more than sixfold higher in the group of
smoking smelters and about fivefold higher in the group
of non-smoking smelters compared to the control groups
(smokers and non-smokers). It was shown that Cd con-
centration in the blood was nearly fivefold higher in the
smoking control group compared to the non-smoking
control group and more than threefold higher in the
group of smoking smelters compared to non-smoking.
It was shown an increased As concentration (more than
fourfold) and decreased Ca concentration in both groups
of smelters compared to control groups. In groups of
smelters (smokers and non-smokers), twofold higher
MDA and AOPP concentrations, and AOPP/albumin
index compared to control groups (smokers and non-
smokers) were shown. Tobacco smoke is the major
source of Cd in the blood of smelters. Occupational
exposure causes accumulation of Pb in the blood. Oc-
cupational exposure to heavy metals causes raise of
MDA concentration and causes greater increase in
AOPP concentration than tobacco smoke.
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Introduction
Free radicals are not only formed continuously during normal
physiological processes, but also as a result of external factors,
including exposure to tobacco smoke in the case of smokers or
to heavy metals in the work environment. In tobacco smoke,
free radicals are responsible for cell damage and apoptosis [1].
They can cause DNA fragmentation, oxidative damage of
cellular membrane lipids and proteins, and the reduction of
enzyme activity through its oxidation and nitration [1–3]. The
most important radicals, which have a strong toxic effect, are
oxygen free radicals—superoxide anion (O2
•−), hydroxyl rad-
ical (•OH−), hydrogen peroxide (H2O2), and nitrogen free
radicals—peroxynitrites (NO2
−) and nitrates (NO3
−) [3]. Ex-
cept to these radicals generated directly, tobacco smoke con-
tains many substances, such as polycyclic aromatic hydrocar-
bons, heterocyclic substances, N-nitrosamines, aromatic
amines, and aldehydes, which are probably the main causes
of biomolecules damage [4, 5]. Components of tobacco
smoke are also metals, e.g., arsenic, beryllium, nickel, chro-
mium, cadmium, polonium, cobalt, and lead [4]. These
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substances have the ability to generate free radicals or catalyze
reactions in which they are produced [3].
Oxidative stress can intensify lipids peroxidation. One of
the most common products of lipid peroxidation is
malonylodialdehyde (MDA), which is also generated in the
process of biosynthesis of prostaglandins. MDA can be trans-
mitted to distant tissues and, thanks to the possibility of
forming covalent bonds with other molecules, modifies their
structure, and consequently, changes its properties. MDA has
high cytotoxicity, is mutagenic, and inhibits the activity of
various enzymes, leading to inhibition of DNA replication,
transcription, and breathing [6, 7]. MDA is considered as a
marker of oxidative damage of cell membrane. It is formed
from the decomposition of primary and secondary lipids per-
oxidation products [8, 9]. Another component of the cell
which is characterized by its particular susceptibility to oxi-
dative damage is DNA [7]. Free radicals can react with both
purine and pyrimidine bases, as well as the deoxyribose.
Oxidative stress can damage DNA comprising: breaking sin-
gle or double strand, base modifications, deoxyribose modifi-
cations, and crosslinks formation. When DNA damage is not
repaired before or during replication, this can lead to cell
death, mutations, replication errors, and instability of the
genome, each of which is associated with the process of
carcinogenesis [6]. Of all the DNA nitrogen bases, guanine
is the most susceptible to oxidation [10, 11]. Hydroxyl radical
addition to the eighth position of the molecule leads to the
f o rm a t i o n o f g u a n i n e mod i f i e d p r o d u c t— 8 -
hydroxydeoxyguanosine (8-OHdG) [11, 12]. Mutagenic char-
acter of 8-OHdG located in the DNA template is due to its
potential for incorrect base pairing during replication. 8-
OHdG is capable of transversion G:C → T:A. It has been
shown that such transversions are common in human cancers
and are especially prevalent in the p53 tumor suppressor gene.
This indicates the importance of 8-OHdG as an endogenous
mutagen and its potential role in tumorigenesis [13].
Exposure of proteins to reactive oxygen species results in
modification of amino acid residues, what alters protein struc-
ture and function [5]. The changes in proteins, which are
induced by exposure to tobacco smoke, such as an increase
of carbonyl groups content in the protein molecule were
shown [3, 14]. The protein oxidation can be caused also by
the exposure on heavy metals, which are present in living or/
and occupational environment. The broad spectrum of heavy
metals toxicity, such as Pb, Cd, and As, resulting from their
ability to selective interaction with the fragments of protein
chain, may induce the production of oxygen free radicals [15].
This toxicity of heavy metals can be reduced by the presence
of Ca and Mg—an important macronutrients, which limit the
absorption of metals, such as Cd and Pb, in human and
animals organisms [16, 17].
Albumin is a major protein of blood plasma, where it
constitutes about 55 % of all proteins. This protein is also a
major and predominant antioxidant in plasma [18]. The ability
of the albumin to perform these functions has a relationship
with its structure, which may be destroyed by oxidative stress.
Free radicals can interact with each other or with amino acids/
proteins. The modifications of amino acids lead to an increase
of carbonyl groups and disulphides in the protein molecule,
and reduce the number of α-helices, what results in confor-
mational changes of proteins [3, 19, 20]. The influence on the
albumin function, in particular on its ability to transport, have
not only free radicals, but also heavy metal ions. Their binding
to albumin is in competition with other physiological sub-
stances transported by albumin. Toxic metals, as compounds
with high affinity to the hydrophobic sites of albumin, cause a
conformational change of the protein molecule, the amino
acids oxidation, and the weakness of the ability to binding
other ligands. In addition, the heavy metal ions present in the
blood cause a chelation of physiological ligands. However,
the strength of the phenomenon is dependent on the type of
metal. In the presence of heavy metal ions, the toxins, which
are transported by albumin, are displaced from the connec-
tions with protein. This results in an increase of free toxins in
the blood, having an impact on the body [21, 22].
The oxidation of proteins, including albumin, leads to the
formation of permanent products, which vary in terms of
structure, function, and physicochemical properties. These
are known as an advanced oxidation protein products
(AOPP) [23]. Although the exact structure of AOPP is not
completely understood, it is known that they are mainly
derivatives of oxidatively modified albumin, its aggregates
and/or fragments, but also fibrinogen and lipoproteins, glyco-
proteins, and globulins (e.g., thyroglobulin and γ-globulins)
[18, 23–26].
The aim of the study was to verify if there is any association
between exposure to metals (Cu, Zn, Cd, Pb, and As) occur-
ring in the work environment of smelters and the formation of
MDA, 8-OHdG, and AOPP and whether in this process
cigarette smoking plays a role. The influence of the exposure
to heavy metals and tobacco smoke on the concentration of Ca
and Mg also was analyzed.
Material and Methods
Materials
The investigations were performed in the whole blood, serum,
plasma, and urine of 352 males working in the copper foundry
and 73 healthy men, non-exposed occupationally to heavy
metals, who were qualified as control group by clinician of
primary medical care. The study protocol was approved by
Local Bioethics Committee of Wroclaw Medical University
(Nr KB: 469/2008). The study population was in similar age
and similar BMI. Table 1 presents data concerning age, BMI,
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years of work in metallurgy, and cotinine concentration in
serum of smelters and persons of control group divided into
smokers (22 pack years of smoking) and non-smokers: 258
smoking smelters, 94 non-smoking smelters, 14 smokers of
control group, and 59 non-smokers of control group. Data
about smoking were obtained from direct personal interview
and were verified by the determination of serum cotinine
concentration—the metabolite of nicotine.
Venous blood was collected in the morning, after 12-h
fasting. Serum was obtained according to the standard proce-
dure by taking venous blood for disposable trace element-free
tubes (No. Cat 03.1524.001, Sarstedt, Germany) with serum
clotting activator, left at 25 °C to complete thrombosis, and
centrifuged (1,200 g/20 min). In order to obtain plasma, blood
was collected into trace element-free tubes containing EDTA-
K2 (No. Cat 04.1931.001, Sarstedt, Germany), immediately
gently mixed, and centrifuged (2,500 g/15 min). The obtained
serum, plasma, and whole blood were portioned and stored in
sealed tubes (No. Cat. 0030102.002, Eppendorf, Germany).
Blood samples of smelters and persons of control groups were
stored at −80 °C until analysis.
The urine was collected in the morning, according to the
standard procedure. Subjects were asked to wash their hands
before supplying the urine, in order to reduce contamination.
Urine samples were stored in special container containing
liquid nitric acid at −20 °C until determination.
Metals Concentration
Concentrations of metals were determined using Solaar M6
aparatus (Solaar House, Cambridge, UK). The Pb concentra-
tion in whole blood (Pb-B) was determined by graphite fur-
nace atomic absorption spectrometry (GFAAS) in the graphite
Massman cuvette, the absorbance measurement at wavelength
λ=283.3 nm, with Zieeman background correction. The
reference material was used BCR-194, -195, -196, IRMM,
EU. The Cd concentration in whole blood (Cd-B) and in urine
(Cd-U) was determined by the samemethod at wavelength λ=
228.8 nm, with Zieeman background correction. The concen-
tration of Zn and Cu in serum (Zn-S and Cu-S) was deter-
mined by flame atomic absorption spectrometry (FAAS) in
air-acetylene flame at wavelength λ=324.8 nm. The reference
material was used Single-Element Zinc (Copper), standard
1000 μg/ml, CPI International. The determination of Ca and
Mg concentrations in serum (Ca-S and Mg-S) was also per-
formed by this method at wavelength λ=422.7 nm for Ca and
λ=285.2 nm for Mg, with deuterium correction of the glass.
As a reference material for these metals was used Seronorm™
Trace Element Serum (Sero, No. 201 405). The As concen-
tration in urine (As-U) (with 65 % HNO3 for acidification)
was determined by FAASmethodwith snap Phillips PU 9360,
used for hydride generation. In this method, wavelength λ=
193.7 nm deuterium background correction and quartz atom-
ization chamber were used.
Creatinine Concentration in Urine
Urinary creatinine level was determined by the Jaffé reaction
[27].
Cotinine Concentration
Serum cotinine concentration was determined using a com-
petitive enzyme immunoassay, the DRG Serum Cotinine
ELISA kit (Cat. No. EIA-3242, DRG International, USA).
The cotinine determination was carried out by the method
described earlier [28, 29].
Plasma MDA Concentration (MDA-P)
Lipid peroxidation was measured in plasma by measuring the
formation of thiobarbituric acid reactive substances (TBARS),
quantified as malondialdehyde (MDA) equivalents, according
to the method described earlier [30, 31]. The amount of MDA
was calculated using an extinction coefficient (1.56×
105 M−1 cm−1). The MDA intensity was measured by spec-
trophotometric method at λ=535 nm. The concentrations of
MDAwere expressed as micromoles per liter in plasma.
Serum 8-OHdG Concentration (8-OHdG-S)
To evaluate the concentration of 8-OHdG in the serum, a
commercial test OxiSelect™DNAOxidative Damage ELISA
Kit was used (Cat. No. STA-320, Cell Biolabs, Inc., USA). To
96-well plate, 100 μl of conjugate 8-OHdG/BSA was added
and incubated overnight at 4 °C, and then washed with H2O.
The next step, 200 μl blocking buffer was added and incubat-
ed at room temperature for 1 h. Fifty microliter of samples and
Table 1 Characteristics of the persons in control group and the group of
smelters
Smoking X ± SD Non-smoking X ± SD
Control group (n=14) (n=59)
Age 34.38±7.90 36.64±11.49
BMI [kg/m2] 26.98±5.48 25.75±3.50
Years of work in smelter – –
Serum cotinine [ng/ml] 66.46±12.18 a 3.46±3.47
Smelters (n=258) (n=94)
Age 42.06±9.06 44.02±8.86
BMI [kg/m2] 26.02±3.66 27.41±3.61
Years of work in smelter 18.98±1.87 19.99±8.82
Serum cotinine [ng/ml] 71.19±12.65a 2.81±1.94
a p<0.0001 compared to non-smoking group
BMI body mass index
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8-OHdG standards were added. After 10 min of incubation,
monoclonal anti-8-OHdG was added (100 μl, 1 h incubation
at room temperature), washed three times followed by addi-
tion of secondary antibody conjugated to horseradish peroxi-
dase (100 μl, 1 h incubation at room temperature). The plate
was washed three times with washing buffer and to each well
100 μl of substrate for peroxidase was added and incubated
for 20min. Followed by the addition of 100μl of reaction stop
solution. A spectrophotometric measurement of absorbance
was performed at a wavelength λ=450 nm. The content of 8-
OHdG in the tested samples was calculated by comparison
with a standard curve determined from standards treated sim-
ilarly to the samples tested.
Plasma AOPP Concentration (AOPP-P)
Determination of AOPP-P concentration was performed by
spectrophotometric method developed by Witko-Sarsat et al.
[26], based on the reaction of AOPP with potassium iodide in
acidic conditions. To 1 ml of plasma, tenfold diluted with
PBS, and to the blank sample (1 ml PBS), 50 μl of potassium
iodide (99 %) and 100 μl of acetic acid (99.5 %) were added
and mixed. The absorbance of samples was measured against
the blank at wavelength λ=340 nm. The results of determina-
tion were expressed in micromoles per liter chloramine T
equivalents and also were converted per gram of albumin
and expressed as AOPP/albumin index (μmol/g).
Serum Albumin Concentration (Alb-S)
Alb-S concentration was determined by using the
bromocresol purple (BCP) (Cat. No. 115−40−2, Sigma-
Aldrich), which reacts with albumin in phosphate buffer saline
(PBS) at pH=6.8. The concentration of albumin standard
(Cat. No. 70024−90−70, Sigma-Aldrich) was determined
using the molar absorption coefficient (A280 nm
0.1 %=0.5).
To make the standard curve, the standard solutions at concen-
trations 0, 11.3, 22.6, 33.9, 45.2, 56.5 g/l were prepared,
which were obtained by the dilution of albumin in PBS.
For each of the tubes, working reagent (with the final
concentration of BCP 40 μmol/l), serum sample, or albumin
standard were added and mixed. All samples were incubated
for 5 min at 25 °C. Absorbances of the standards and of the
samples were measured against the blank sample (working
reagent) at wavelength λ=603 nm. The increase in absorbance
was proportional to the concentration of albumin in the
sample.
Statistical Analysis
Statistical analysis was carried out using the program
Statistica 10.0. Data about examined groups, BMI, age, years
of work in smeltery, and cotinine concentration, were analysed
using ANOVA Kruskal−Wallis test. The concentration of
metals (Cu-S, Zn-S, Pb-B, Cd-B, Cd-U, As-U, Ca-S, and
Mg-S), MDA-P, 8-OHdG, AOPP-P, albumin, and the value
of AOPP/albumin index also using the same test were ana-
lyzed. In order to verify the association between parameters
(age, BMI, concentration of cotinine, metals, MDA-P, AOPP-
P, albumin, and AOPP/albumin index), the multiple linear
regression models were performed. Statistical significance
was accepted for p<0.05.
Results
The Concentrations of Metals
In this study, the concentrations of Cu, Zn, Ca, and Mg in
serum; Pb and Cd in whole blood; and Cd and As in urine
were determined (Table 2). In the smoking smelters, a higher
concentration of Cu in serum (Cu-S) compared to non-
smoking control group was shown. There was no statistically
significant difference in serum Zn (Zn-S) and Mg (Mg-S)
concentrations between smoking and non-smoking smelters,
and between smoking and non-smoking control group. In the
serum of smoking and non-smoking smelters, the decrease of
Ca concentration (Ca-S) in comparison to the smokers and
non-smokers in control group was noted.
In both smoking and non-smoking smelters, a significant
increase in the concentration of Pb in the blood (Pb-B) com-
pared to the control group (smokers and non-smokers) was
observed. In the group of smoking smelters, 6-fold increase in
Pb-B concentration in comparison to the smoking control
group and 7.4-fold higher in relation to the non-smoking
control group were observed. In the group of the non-
smoking smelters, 5.7-fold higher Pb-B concentration com-
pared to the non-smoking control group was observed. The
concentration of Cd in the blood (Cd-B) was significantly
higher at smokers (both the smelters and the control group)
compared to non-smokers. In the blood of smokers (both the
smelters and the control group), 3.3-fold higher Cd concen-
tration compared to the non-smoking smelters and 4.8-fold
higher compared to the non-smoking control group were
observed.
In the group of smoking smelters, 2.5-fold higher
concentration of Cd in urine (Cd-U) compared to the
non-smoking control group was observed. In the urine
of smoking and non-smoking smelters, As concentration
(As-U) was significantly higher compared to control
groups (both smokers and non-smokers). In the smelters
(smoking and non-smoking), more than 4-fold higher of
As-U concentration in comparison to the smoking con-
trol group and more than 4.6-fold higher compared to
the non-smoking control group were observed.
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MDA-P, 8-OHdG-S, and AOPP-P Concentrations as Markers
of Lipids Peroxidation, Oxidatively Modified DNA,
and Protein Oxidation
In the groups of smelters (smokers and non-smokers), 2-fold
higherMDA-P concentration compared to control groups (respec-
tively, smokers and non-smokers) was shown (Table 3). However,
there was no statistically significant difference in 8-OHdG-S
concentration between smoking and non-smoking smelters, and
between smoking and non-smoking control group (Table 3).
In the plasma of smoking and non-smoking smelters, 2-
fold higher of AOPP-P concentration in comparison to the
smoking control group and 2.2-fold higher compared to the
non-smoking control group was shown (Table 3). There were
no statistically significant differences in Alb-S concentration
between smoking and non-smoking smelters, and between
smoking and non-smoking control group (Table 3).
AOPP/albumin index, which is expressed in micromole as
the amount of AOPP per gram of albumin, was calculated. In
the group of smoking smelters, 1.7-fold increase in the value
AOPP/albumin index compared to the smoking control group
and 3-fold increase of this parameter compared to the non-
smoking control group was observed. 2.3-fold increase in the
value of AOPP/albumin index in the non-smoking smelters
compared to non-smoking control group was observed
(Table 3).
Correlations
In the serum of non-smoking smelters, the correlation was
demonstrated between the concentration of Cu-S and Alb-S
(r=−0.4646, p=0.0103). The correlation of Pb-B and AOPP-
P concentrat ions (r = 0.5219, p = 0.0073), and the
AOPP/albumin index (r=0.3689, p=0.0369) in this group
also were shown.
Discussion
Tobacco smoke and environmental or occupational exposure
to heavy metals can cause many health effects in organism of
copper foundry workers. Depending on intensity and duration
of the exposure, they can change the biological functions of
organs, such as liver and kidney. Lead, arsenic, and cadmium
belong to toxic agents, which can disturb function of cardio-
vascular system. Heavy metals can produce free radicals,
which leads to pro-oxidant/antioxidant imbalance and oxida-
tive stress. It leads to the disturbances of cellular metabolism
resulting in the formation of permanent changes caused by the
oxidation in the structure of lipids, proteins, and DNA [32].
The oxidation products are MDA, AOPP and 8-OHdG re-
spectively. The association of the MDA, 8-OHdG, and AOPP
formation and oxidative stress was confirmed in subsequent
studies [2, 18, 26, 33–38].
It was demonstrated that occupational exposure causes an
increase in serum Cu concentration in smelters (104.5±
15.1 μg %) compared to controls (99.7±12.1 μg %) [39].
Also, in our study, the highest Cu-S concentration in the group
of smoking smelters was shown. This indicates that Cu-S
concentration was increased with the number of oxidizing
factors, especially during exposure to heavy metals. It con-
firmed that Cu can be replaced through heavy metals in
Table 2 Influence of cigarette
smoking on the metals concen-
trations in the group of smelters
and control group
a p<0.05 compared to smoking
control group
b p< 0.05 compared to non-
smoking control group
c p< 0.05 compared to non-
smoking smelters
Cu-S Cu concentration in serum;
Zn-S Zn concentration in serum;
Pb-B Pb concentration in the
blood; Cd-B Cd concentration in
the blood;Cd-U Cd concentration
in urine; As-UAs concentration in
urine; Ca-S Ca concentration in
serum; Mg-S Mg concentration
in serum














107.22±13.22b 104.00±13.63 102.29±13.46 97.76±10.66
Zn-S
[μg/100 ml]
101.22±23.37 97.60±18.44 99.22±10.67 96.97±9.22
Pb-B
[μg/l]
229.91±127.75a,b 177.91±125.17a,b 37.95±14.15 31.01±7.91
Cd-B
[μg/l]
1.52±0.98b,c 0.46±0.33a 1.52±0.77b 0.32±0.10
Cd-U [μg/g creatinine] 0.83±0.66a,b 0.56±0.41 0.44±0.26 0.32±0.20
As-U
[μg/g creatinine]
12.76±7.69a,b 13.01±9.56a,b 3.14±2.16 2.73±1.24
Ca-S
[μg/ml]
89.81±8.03a,b 90.77±8.34a,b 97.59±4.64 100.02±4.02
Mg-S
[μg/ml]
21.08±2.01 20.62±1.10 19.76±1.64 20.70±1.70
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antioxidant enzymes, such as Cu/Zn superoxide dismutase
(EC 1.15.1.1), which can result in the inhibition of antioxidant
enzymes activity and an increase in oxidative stress [40]. On
the other hand, in our study, there was no difference in Zn-S
concentration in examined groups. It suggested the adaptation
of healthy smelters to the environmental conditions, which
was shown in others studies [41].
Bizoń et al. (2013) demonstrated that exposure to heavy
metals causes an increase of Pb-B concentration [42]. Higher
Pb-B concentration in the group of persons exposed to heavy
metals (277.18±119.14 μg/l) compared to the control group
(32.11±8.89 μg/l) was shown [42]. In other studies, a signif-
icant increase in Pb-B concentration in the group of smelters
(201.2±112.5 μg/l) compared to the people not exposed to
this metal (37.9±27.1 μg/l) was also shown [39]. In our
study, a significant increase in Pb-B concentration in the
groups of smelters compared to the control groups was
observed. In the smoking smelters, the concentration of
Pb was nearly sixfold higher in comparison to the non-
smoking control group. It was also shown that Pb-B
concentration in the group of smelters almost twofold
exceeded the permissible level of this metal in the blood
(<100 μg/l) [39, 43]. The Pb-B concentrations in the
control groups were smaller than 100 μg/l. This con-
firms that the high Pb-B concentration was caused
mainly by occupational exposure, and cigarette smoking
was not the main source of Pb-B.
Cd-B and Cd-U concentrations increase during exposure to
tobacco smoke, that was observed by other scientists. Bizoń
et al. (2013) demonstrated an increase in Cd-B concentration
of smokers compared to non-smokers, both in the control
group and the group of smelters (0.43±0.39 μg/l, 1.59±
0.79 μg/l and 1.69±0.70 μg/l, respectively, for the non-
smoking control group and smoking control group <20
cigarettes/day and >20 cigarettes/day and 0.54±0.44 μg/l,
2.19±1.51 μg/l and 3.05±2.29 μg/l, respectively, for non-
smoking and smoking smelters <20 cigarettes/day and >20
cigarettes/day) [42]. In other studies, the difference between
Cd-B concentration in smokers (1.3 μg/l) and non-smokers
(0.4 μg/l) was shown [44]. Madeddu et al. (2011) also dem-
onstrated that cigarette smoking causes an increase of the Cd-
B concentration (0.46 and 0.29 μg/l, respectively, for smokers
and non-smokers) [45]. In this study, nearly fivefold higher of
Cd-B concentration in the group of smokers compared to non-
smokers (both smelters and the control group) was shown.
Cd-B concentration in the group of smokers (both smelters
and the control group) exceeded about threefold the value of
permissible level (<0.5 μg/l) [39, 43]. In the group of non-
smokers (both smelters and the control group), it did not
exceed the permissible value. This emphasizes the importance
of the influence of cigarette smoking on Cd-B concentration.
It was observed higher Cd-U concentration in the smoking
groups compared to non-smoking groups (both smelters and
the control group). It was noted a higher Cd-U concentration
in the group of smoking smelters compared to the smoking
control group. It can suggest that occupational exposure to
heavy metals accompanying exposure to tobacco smoke
raised Cd-U concentration. This data confirmed that the main
factor influencing on the Cd-B and Cd-U concentration is
cigarette smoking. Occupational exposure to this metal seems
Table 3 Influence of cigarette smoking on MDA, 8-OHdG, AOPP, albumin concentrations, and AOPP/albumin index in the group of smelters and
control group














1.56±0.76a,b 1.54±0.65a,b 0.74±0.12 0.80±0.24
8-OHdG-S
[ng/ml]
2.73±0.31 2.63±0.41 2.60±0.48 2.61±0.38
AOPP-P
[μmol/l]
57.63±22.53a,b 59.46±21.98a,b 30.85±12.95 25.93±10.31
Alb-S [g/l] 50.67±8.58 52.52±8.89 53.14±6.62 51.00±8.07
AOPP/albumin index
[μmol/g]
1.09±0.50a,b 1.14±0.46a,b 0.64±0.18b 0.49±0.17
a p<0.05 compared to smoking control group
b p<0.05 compared to non-smoking control group
c p<0.05 compared to non-smoking smelters
AOPP-P AOPP concentration in plasma; Alb-S Albumin concentration in serum; MDA-P MDA concentration in plasma; 8-OHdG-S 8-hydroxy-2'-
deoxyguanosine concentration in serum
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to have lower importance on its concentration in the human
body than cigarette smoking.
An increase of As-U concentration in the group of persons
occupationally exposed to heavy metals (18.9±22.2 μg/g
creatinine) in comparison to the control group (3.5±3.0 μg/g
creatinine) was observed [39]. Bizoń et al. (2013) also have
shown higher As-U concentration in smelters compared to the
control group [42]. Our study confirmed the influence of
occupational exposure on As-U, because in the groups of
smelters (smokers and non-smokers) more than fourfold an
increase in As-U concentration compared to the control
groups was shown. It was also observed that in the group of
smelters, As-U concentration exceeded the value of permissi-
ble level (<10 μg/g creatinine) [39].
The concentrations of Ca and Mg macroelements, which
values have a significant impact on the reduction of the
penetration capability of some toxic metals, such as Cd and
Pb were also determined. The demonstrated differences in Ca-
S concentration between the groups of smelters and control
groups (both smokers and non-smokers) confirm that expo-
sure to heavy metals causes a decrease Ca-S concentration.
These results are similar to the study made by Kossowska
et al., where was demonstrated a difference between Ca-S
concentration in the group of smelters (90.4±7.3 μg/ml) and
the control group (99.3±4.1 μg/ml) [39]. In our study, the
influence of occupational exposure and cigarette smoking on
Mg-S concentration was not observed. It is known that Mg
has antioxidant properties, scavenging oxygen radicals, pos-
sibly by affecting the rate of spontaneous dismutation of the
superoxide ion [46]. It was shown that Mg can inhibit lipo-
protein oxidation and enhances the antioxidant enzymes ac-
tivity, which reduces oxidative stress [47]. In our study, this
effect was not observed. There was no difference in Mg-S
concentration between examined groups. It can suggest that
lipids peroxidation and protein oxidation in smelters were not
mediated thought reduced level of Mg-S or its deficiency.
Chronic exposure to heavy metals causes their accumula-
tion in tissues and has the influence on the human health
[48–50]. It was observed an increase in the concentration of
Pb-B, Cu-S, and As-U in the group of smelters, which con-
firms that the occupational exposure is the source of these
metals. However, Cd-B concentration increases during expo-
sure to tobacco smoke. Both occupational exposure to heavy
metals and tobacco smoke intensify the oxidative stress. It
results in the lipids peroxidation expressed as MDA produc-
tion and/or protein oxidation and the formation of AOPP.
There was observed significantly higher plasma MDA
levels (2.67±0.69 μM) of workers exposed to lead than those
in the control group (1.23±0.61 μM) [51]. However, the
results presented by Dursun et al. indicate that increased
concentrations of lipid peroxidation products in the blood of
persons exposed to lead is dependent not only on the concen-
trations of lead, but also on the age and time of exposure [51].
Other researches have also shown that MDA concentrations
were elevated in the all heavy metal-treated groups compared
to the control groups [52]. In this study, MDA concentrations
in the group of smelters (both smokers and non-smokers) were
nearly 2-fold higher compared to smoking and non-smoking
control groups, which confirms that oxidative stress is gener-
ated in the result of occupational exposure in the smeltery.
Increased concentration of MDA confirms the relationship
between occupational exposure to heavy metals and the de-
velopment of oxidative stress, and its effect on cell mem-
branes. An increase in lipids peroxidation in smelters is a
major sign of oxidative stress in the blood, which can result
in the changes of tissues and organs.
Barbato et al. (2010) conducted a meta-analysis in envi-
ronmental pollution exposed employees and in five studied
groups, increase of 8-OHdG in the urine was observed, and in
three studied group, there was no effect [53]. Garçon et al.
(2007) studied the effects of chronic exposure to cadmium and
lead on kidney function, they have also not observed differ-
ences in the concentration of the marker in the urine between
smelters and control group (respectively, 12.7±5.6 and 12.4±
5.9 μg/g creatinine) [54]. Wu et al. (2004) have not found any
difference in the concentration of 8-OHdG in urine among
smokers and people not exposed to tobacco smoke [11].
Musarrat et al. (1996) also found that adducts of 8-OHdG
concentration does not correlate with smoking [55]. This
study has shown no significant difference in the level of
8-OHdG concentration in none of group. This indicates that
both cigarette smoking and metals exposure appear to have
only a small effect on 8-OHdG level in the blood.
It should be noted that AOPP concentration depends on
many physiological and environmental factors, which may
influence on the examined population (age, body weight,
sex, environmental pollution, cigarette smoking, and physical
condition) [56–59]. The impact of additional factors, except
tested factors, is so large that wrong classification to the
control group or not adequate comparison of obtained results
with these from other studies can make the results
uncomparable. This is confirmed by the fact of the lack of
standardized method for the determination of AOPP, which
was noticed by other researchers [18]. In this study, examined
groups were standardized in terms of sex, age, BMI, and
environmental exposure to heavy metals.
There are some studies demonstrating the impact of ciga-
rette smoking on the formation the changes in the structure of
proteins. It was shown an increase in the amount of carbonyl
groups in the molecules of proteins, which are the component
of AOPP. A difference in the amount of carbonyl groups was
shown between the group of persons, which were intensive
smokers (4.00±1.31 nmol/mg protein) and the persons not
exposed to tobacco smoke (0.80±1.94 nmol/mg protein) [14].
However, others researchers found no differences in concen-
tration of carbonyl groups between current and former
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smokers (17.9±2.9 nmol/ml plasma for both groups) [5]. Also
was shown no difference in the concentration of carbonyl groups
between persons, which were a long-term smokers (17.9±2.8
and 17.9±3.1 nmol/ml plasma, respectively, for smokers 30
−45 years and >45 years), and the persons, which were smokers
<30 years (17.7±2.7 nmol/ml plasma) [5]. In some studies, it
was shown that the tobacco smoking has no influence on the
structure of proteins; in others, it was shown that it can induce
protein oxidation measured as the increase in the amount of
carbonyl groups in their molecules. This indicates that the influ-
ence of tobacco smoking on the changes in proteins structure and
the formation of AOPP are not clearly defined. In our study, it
was shown no influence of tobacco smoke on an increase of
AOPP-P concentration. However, AOPP-P concentration was
more than twofold higher in the groups of smelters than in the
control groups. This indicates an influence of occupational ex-
posure on protein oxidation. Occupational exposure to heavy
metals causes a significant increase in AOPP-P concentration.
Differences in this parameter resulting from the impact of tobac-
co smoke on protein oxidation were less visible than resulting
from occupational exposure.
Because of the fact that in the composition of AOPP ismainly
the products of albumin’s oxidation; the determination of this
protein in the serum of smelters was an important element of this
study. On the concentration of AOPP, it has an influence not only
in many factors discussed above, but also the concentration of
albumin in the blood of the examined persons, which were in
reference range (35–55 g/l) [60]. For this reason, the parameter
better expressing the changes in AOPP concentration is its
conversion per gram of albumin in the blood [61–62]. The
expression of AOPP concentration as AOPP/albumin index in
this study allowed to make the amount of AOPP independent
from the inter-person variability in the concentration of albumin.
This enables to better define an exposure to oxidation factors
(heavy metals and tobacco smoke). In this study, the conversion
of AOPP per gram of albumin permitted to detect a statistically
significant difference in the AOPP-P concentration between
smoking and non-smoking control group. This difference was
not detected in the case of AOPP-P concentration expressed in
micromoles per liter (using the same statistical test for both
parameters). It was shown that the value of AOPP/albumin index
increased with the exposure to factors causing the formation of
AOPP (heavy metals and also tobacco smoke).
In this study, it was demonstrated that an important factor
influencing AOPP-P concentration is occupational exposure
to heavy metals, especially Cu. The inverse correlation be-
tween Cu-S and Alb-S concentration may indicate the partic-
ipation of Cu in the formation of AOPP and its oxidation
effect on albumin. In the group of non-smoking smelters, it
was demonstrated the correlation between the concentration
of Pb-B and AOPP-P, and the value of AOPP/albumin index.
This may indicate that high Pb-B concentration is an oxidation
factor for proteins. These results suggest that Cu and Pb play
an important role in protein oxidation. Cu can generate free
radicals by Fenton reaction. Additionally, Pb can replace Cu in
antioxidant enzymes that causes an increase in serum Cu
concentration and intensifies an oxidative stress.
In this study, it was confirmed the influence of heavy
metals exposure on lipids peroxidation. It indicates that occu-
pationally exposure can have an important role in lipid deg-
radation and cell damage. It was not observed any effect of
heavy metals exposure or cigarette smoking on oxidative
modification of DNA. It was shown that cigarette smoking
and occupational exposure to heavy metals have an influence
on protein oxidation. These oxidizing factors of which the
source is the environment seem to be important for destruction
of protein molecule and limit its function.
Conclusions
In this study, it was confirmed that tobacco smoke is the main
source of Cd in the blood of smelters. The occupational exposure
on heavy metals has no influence on Cd-B and Cd-U concentra-
tions. With the increasing exposure to tobacco smoke and heavy
metals, Ca concentration in serum was decreased.
Exposure to heavy metals causes an increase of heavy
metals concentrations in the blood, especially Pb-B, but also
Cu-S and As-U of smelters. This oxidizing factor intensifies
lipids peroxidation and causes an increase in MDA concen-
tration, but they have no influence on DNA. The intensity of
AOPP formation depends on the type of factor that it causes—
for smelters, occupationally exposure to heavy metals is a
stronger oxidation factor than tobacco smoke. The strongest
oxidation effect on the protein has Cu and Pb.
Acknowledgments This work was supported by the grant from
Wroclaw Medical University. The authors gratefully thank Professor
Jolanta Antonowicz-Juchniewicz from Department of Internal and Occu-
pational Medicine, Wroclaw Medical University, Poland for her support
in biological material collection.
Conflict of interest statement The authors declare that they have no
conflict of interest.
Statement All persons gave their informed consent prior to their inclu-
sion in the study.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. Asano H, Horinouchi T, Mai Y, Sawada O, Fujii S, Nishiya T,
Minami M, Katayama T, Iwanaga T, Terada K, Miwa S (2012)
Nicotine- and tar-free cigarette smoke induces cell damage through
66 Ściskalska et al.
reactive oxygen species newly generated by PKC-dependent activa-
tion of NADPH oxidase. J Pharmacol Sci 118:275–287
2. Valavanidis A, Vlachogianni T, Fiotakis K (2009) Tobacco smoke:
involvement of reactive oxygen species and stable free radicals in
mechanisms of oxidative damage, carcinogenesis and synergistic
effects with other respirable particles. Int J Environ Res Public
Health 6:445–462
3. Weiner D, Khankin EV, Levy Y, Reznick AZ (2009) Effects of cigarette
smoke borne reactive nitrogen species on salivaryα-amylase activity and
protein modifications. J Physiol Pharmacol 60:127–132
4. Starek A, Podolak I (2009) Carcinogenic effect of tobacco smoke.
Rocz Panstw Zakl Hig 60:299–310
5. Yeh C, Barr RG, Powell CA, Mesia-Vela S, Wang Y, Hamade NK,
Austin JHM, Santella RM (2008) No effect of cigarette smoking dose
on oxidized plasma proteins. Environ Res 106:219–225
6. Klaunig JE, Wang Z, Pu X, Zhou S (2011) Oxidative stress and
oxidative damage in chemical carcinogenesis. Toxicol Appl
Pharmacol 254:86–99
7. Valavanidis A, Vlahogianni T, Dassenakis M, Scoullos M (2006)
Molecular biomarkers of oxidative stress in aquatic organisms in
relation to toxic environmental pollutants. Ecotoxicol Environ Saf
64(2):178–189
8. HeX, Nie X,Wang Z, Cheng Z, Li K, Li G, HungWongM, LiangX,
Tsui MT (2011) Assessment of typical pollutants in waterborne by
combining active biomonitoring and integrated biomarkers response.
Chemosphere 84:1422–1431
9. Zhang XY, Tan YL, Zhou DF, Haile CN, Wu GY, Cao LY, Kosten TA,
Kosten TR (2007) Nicotine dependence, symptoms and oxidative stress
in male patients with schizophrenia. Neuropsychopharmacology 32:
2020–2024
10. Delaney S, Jarem DA, Volle CB, Yennie CJ (2012) Chemical and
biological consequences of oxidatively damaged guanine in DNA.
Free Radic Res 46:420–441
11. Wu LL, Chiou CC, Chang PY, Wu JT (2004) Urinary 8-OHdG: a
marker of oxidative stress to DNA and a risk factor for cancer,
atherosclerosis and diabetics. Clin Chim Acta 339:1–9
12. Valavanidis A, Vlachogianni T, Fiotakis C (2009) 8-hydroxy-2' -
deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress
and carcinogenesis. J Environ Sci Health C Environ Carcinog
Ecotoxicol Rev 27:120–139
13. Pilger A, Rüdiger HW (2006) 8-Hydroxy-2'-deoxyguanosine as a
marker of oxidative DNA damage related to occupational and envi-
ronmental exposures. Int Arch Occup Environ Health 80:1–15
14. Pignatelli B, Li CQ, Boffetta P, Chen Q, Ahrens W, Nyberg F,
Mukeria A, Bruske-Hohlfeld I, Fortes C, Constantinescu V,
Ischiropoulos H, Ohshima H (2001) Nitrated and oxidized plasma
proteins in smokers and lung cancer patients. Cancer Res 61:778–784
15. Zampella G, Neupane KP, De Gioia L, Pecoraro VL (2012) The
importance of stereochemically active lone pairs for influencing Pb II
and As III protein binding. Chem Eur J 18:2040–2050
16. Herman DS, Geraldine M, Venkatesh T (2009) Influence of minerals
on lead-induced alterations in liver function in rats exposed to long-
term lead exposure. J Hazard Mater 166:1410–1414
17. Goyer RA (1993) Lead toxicity: Current concerns. Environ Health
Perspect 100:177–187
18. Selmeci L (2011) Advanced oxidation protein products (AOPP):
Novel uremic toxins, or components of the non-enzymatic antioxi-
dant system of the plasma proteome? Free Radic Res 45:1115–1125
19. Anraku M, Yamasaki K, Maruyama T, Kragh-Hansen U, Otagiri M
(2001) Effect of oxidative stress on the structure and function of
human serum albumin. Farm Res 18:632–639
20. IwaoY,AnrakuM,Yamasaki K,Kragh-HansenU,KawaiK,Maruyama
T, Otagiri M (2006) Oxidation of Arg-410 promotes the elimination of
human serum albumin. Biochim Biophys Acta 1764:743–749
21. Peng M, Shi S, Zhang Y (2012) The influence of Cd2+, Hg2+ and
Pb2+ on taxifolin binding to bovine serum albumin by spectroscopic
methods: With the viewpoint of toxic ions/drug interference. Environ
Toxicol Pharmacol 33:327–333
22. Zhang Z, Shuyun S, Liu Y, ChenX, PenM (2011) Differential effects
of Cu (II) and Fe (III) on the binding of omeprazole and pantoprazole
to bovine serum albumin: Toxic effect of metal ions on drugs. J Farm
Biomed Anal 56:1064–1068
23. Liu B, Hou X, Zhou Q, Tian J, Zhu P, Xu J, Hou F, Fu N (2011)
Detection of advanced oxidation protein products in patients with
chronic kidney disease by a novel monoclonal antibody. Free Radic
Res 45:662–671
24. Capeillére-Blandin C, Gausson V, Descamps-Latscha B, Witko-
Sarsat V (2004) Biochemical and spectrophotometric significance
of advanced oxidized protein products. Biochim Biophys Acta 1689:
91–102
25. Selmeci L, Székely M, Soós P, Seres L, Klinga N, Geiger A, Acsády
G (2006) Human blood plasma advanced oxidation protein products
(AOPP) correlates with fibrinogen levels. Free Radic Res 40:952–
958
26. Witko-Sarsat V, Friedlander M, Capeillére-Blandin C, Nguyen-Khoa
T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B (1996)
Advanced oxidation protein products as a novel marker of oxidative
stress in uremia. Kidney Int 49:1304–1313
27. Butler AR (1975) The Jaffe reaction. Identification of the coloured
species. Clin Chim Acta 59:227–232
28. Bizoń A, Milnerowicz-Nabzdyk E, Zalewska M, Zimmer M,
Milnerowicz H (2011) Changes in pro/antioxidant balance in
smoking and non-smoking pregnant women with intrauterine growth
restriction. Reprod Toxicol 32:360–367
29. Zalewska M, Królik M, Milnerowicz H (2011) Impact of working in
metallurgy and cigarettes smoking on the concentration of
malonylodialdehyde and 8-hydroksydeoxyguanosine in the blood.
Przegl Lek 68:770–774
30. Bouki E, Dimitriadis VK, Kaloyianni M, Dailianis S (2013)
Antioxidant and pro-oxidant challenge of tannic acid in mussel
hemocytes exposed to cadmium. Mar Environ Res 85:13–20
31. Chatziargyriou V, Dailianis S (2010) The role of selenium-dependent
glutathione peroxidase (Se-GPx) against oxidative and genotoxic
effects of mercury in haemocytes of mussel Mytilus galloprovincialis
(Lmk.). Toxicol In Vitro 24:1363–1372
32. Hanasand M, Omdal R, Norheim KB, Gøransson LG, Brede C,
Jonsson G (2012) Improved detection of advanced oxidation protein
products in plasma. Clin Chim Acta 413:901–906
33. BulutM, Selek S, Bez Y, KayaaMC,GunesaM,Karababac F, Celikd
H, Savase HA (2013) Lipid peroxidation markers in adult attention
deficit hyperactivity disorder: new findings for oxidative stress.
Psychiatry Res 209:638–642
34. Guo CH, Chen PC, Lin KP, Shih MY, Ko WS (2012) Trace metal
imbalance associated with oxidative stress and inflammatory status in
anti-hepatitis C virus antibody positive subjects. Environ Toxicol
Pharmacol 33:288–296
35. Hawkins CL, Pattison DI, Davies MJ (2003) Hypochlorite-induced
oxidation of amino acids, peptides and proteins. Amino Acids 25:
259–274
36. Jomova K, Valko M (2011) Advances in metal-induced oxidative
stress and human disease. Toxicology 283:65–87
37. Piwowar A, Knapik-Kordecka M, Warwas M (2007) AOPP and its
relations with selected markers of oxidative/antioxidative system in
type 2 diabetes mellitus. Diabetes Res Clin Pract 77:188–192
38. Witko-Sarsat V, Gausson V, Nguen A, Touam M, Drüeke T,
Santangelo F, Descamps-Latscha B (2003) AOPP-induced activation
of human neutrophil and monocyte oxidative metabolism: a potential
target for N-acetylcysteine treatment in dialysis patients. Kidney Int
64:82–91
39. Kossowska B, Dudka I, Bugla-Płoskońska G, Szymańska-
Chabowska A, Doroszkiewicz W, Gancarz R, Andrzejak R,
Antonowicz-Juchniewicz J (2010) Proteomic analysis of serum of
Heavy Metals and Tobacco Smoke Induce the Oxidative Stress 67
workers occupationally exposed to arsenic, cadmium, and lead for
biomarker research: a preliminary study. Sci Total Environ 408:
5317–5324
40. Flora SJS, Mittal M, Mehta A (2008) Heavy metal induced oxidative
stress and its possible reversal by chelation therapy. Indian J Med Res
128:501–523
41. Antonowicz J, Andrzejak R, Lepetow T, Skoczyńska A, Smolik R
(1996) Blood lipid parameters in smelters chronically exposed to
heavy metals. Med Pr 47:207–215
42. Bizoń A, Antonowicz-Juchniewicz J, Andrzejak R, Milnerowicz H
(2013) The influence of the intensity of smoking and years of work in
the metallurgy on pro-oxidant/antioxidant balance in the blood of
smelters. Toxicol Ind Health 29:149–161
43. Szkup-JabłońskaM, Karakiewicz B, Grochans E, JurczakA,Nowak-
Starz G, Rotter I, Prokopowicz A (2012) Effects of blood lead and
cadmium levels on the functioning of children with behaviour disor-
ders in the family environment. Ann Agric EnvironMed 19:241–246
44. Batáriová A, Spevácková V, Benes B, Cejchanová M, Smíd J, Cerná
M (2006) Blood and urine levels of Pb, Cd and Hg in the general
population of the Czech Republic and proposed reference values. Int
J Hyg Environ Health 209:359–366
45. Madeddu R, Solinas G, Forte G, Bocca B, Asara Y, Tolu P, Delogu
LG, Muresu E, Montella A, Castiglia P (2011) Diet and nutrients are
contributing factors that influence blood cadmium levels. Nutr Res
31:691–697
46. Hans CP, Chaudhary DP, Bansal DD (2003) Effect of magnesium
supplementation on oxidative stress in alloxanic diabetic rats.
Magnes Res 16:13–19
47. Lü X, Wang R (2002) Protective effect of magnesium on the dam-
aged cultured endothelial cells induced by oxidized low density
lipoprotein. Wei Sheng Yan Jiu 31:244–246
48. Olawoyin R, Oyewole SA, Grayson RL (2012) Potential risk effect
from elevated levels of soil heavy metals on human health in the
Niger delta. Ecotoxicol Environ Saf 85:120–130
49. Zhang X, Yang L, Li Y, Li H, Wang W, Ye B (2012) Impacts of
lead/zinc mining and smelting on the environment and human health
in China. Environ Monit Asses 184:2261–2273
50. Żukowska J, Biziuk M (2008) Methodological evaluation of method
for dietary heavy metal intake. J Food Sci 73:21–29
51. Dursun N, Dogan P, Donmez H (2001) Plasma and erythrocyte lipid
peroxide levels in workers with occupational exposure to lead. Biol
Trace Elem Res 82:29–34
52. Turkez H, Geyikoglu F, Tatar A, Keles MS, Kaplan I (2012) The
effects of some boron compounds against heavy metal toxicity in
human blood. Exp Toxicol Pathol 64:93–101
53. BarbatoDL, Tomei G, Tomei F, Sancini A (2010) Traffic air pollution
and oxidatively generated DNA damage: can urinary 8-oxo-7,8-
dihydro-2-deoxiguanosine be considered a good biomarker? A
meta-analysis. Biomarkers 15:538–545
54. Garçon G, Leleu B, Marez T, Zerimech F, Haguenoer JM, Furon D,
Shirali P (2007) Biomonitoring of the adverse effects induced by the
chronic exposure to lead and cadmium on kidney function:
Usefulness of alpha-glutathione S-transferase. Sci Total Environ
377:165–172
55. Musarrat J, Arezina-Wilson J, Wani AA (1996) Prognostic and
aetiological relevance of 8-hydroxyguanosine in human breast carci-
nogenesis. Eur J Cancer 32A:1209–1214
56. Çakatay U, Kayali R, Uzun H (2008) Relation of plasma protein
oxidation parameters and paraoxonase activity in the ageing popula-
tion. Clin Exp Med 8:51–57
57. Chirico EN, Martin C, Faës C, Féasson L, Oyono-Enguéllé S,
Aufradet E, Dubouchaud H, Francina A, Canet-Soulas E,
Thiriet P, Messonnier L, Pialoux V (2012) Exercise training
blunts oxidative stress in sickle cell trait carriers. J Appl
Physiol 112:1445–1453
58. Selmeci L, Seres L, Antal M, Lukács J, Regöly-Mérei A,
Acsády G (2005) Advanced oxidation protein products
(AOPP) for monitoring oxidative stress in critically ill pa-
tients: a simple, fast and inexpensive automated technique.
Clin Chem Lab Med 43:294–297
59. Venturini D, Simão AN, Scripes NA, Bahls LD, Melo PA, Belinetti
FM (2012) Evaluation of oxidative stress in overweight subject with
or without metabolic syndrome. Obesity 20:2361–2366
60. Dembińska-Kieć A, Drożdż R, Naskalski J (2010) Plasma proteins.
In: Dembińska-KiećA, Naskalski J (eds) Diagnostic Laboratory with
the elements of clinical biochemistry, 3rd edn. Elsevier Urban &
Partner, Wrocław, p 200
61. Matteucci E, Giampietro O (2000) Oxidative stress in families of type
1 diabetic patients. Diabetes Care 23:1182–1186
62. Šebeková K, Klenoviscová K, Ferenczová J, Hedwig J,
Podracká L, Heidland A (2012) Advanced oxidation protein
products and advanced glycation end products in children and
adolescents with chronic renal insufficiency. J Ren Nutr 22:
143–148
68 Ściskalska et al.
